Latest Competition News

EPX Limited has launched a Share Purchase Plan offering eligible shareholders the chance to buy new shares at $0.25 each, matching a recent institutional placement price. The plan aims to raise up to $700,000 to support the company’s growth and working capital needs.

AnteoTech secures a significant order from the Serum Institute of India and expands its Life Sciences pipeline with new product developments and global partnerships, positioning for accelerated growth in 2026.

DigiCo Infrastructure REIT has received key regulatory approval to expand its SYD1 data centre in Ultimo, NSW, enabling a significant capacity upgrade amid strong tenant demand.

Weebit Nano has raised its FY26 revenue guidance to a minimum of $10 million following the signing of multiple IP licensing agreements with semiconductor fabs and product companies.

Blackstone Minerals announces the resignation of Managing Director Scott Williamson, appointing Geoff Gilmour as Executive Chairman during the search for a new CEO. The board also welcomes geologist Greg Cunnold to strengthen technical expertise amid this transition.

Seven West Media Limited shares have been suspended from the ASX following court approval of its acquisition by Southern Cross Media Group, marking a significant shift in Australian media ownership.

Southern Cross Media Group has secured legal approval to acquire Seven West Media, marking a significant consolidation in Australia's media landscape. Seven West Media shares will be suspended as the scheme moves to implementation.

Comms Group Limited has finalized a new three-year debt refinancing agreement with Westpac, improving its financial flexibility and positioning for future acquisitions.

The Supreme Court of New South Wales has approved the acquisition of Seven West Media by Southern Cross Media, marking a major consolidation in Australian media. SWM shares will be suspended from trading as shareholders prepare to receive Southern Cross shares in early January.

Proteomics International Laboratories has achieved the prestigious CAP accreditation for its US lab and installed a new mass spectrometry platform, setting the stage for the 2026 launch of its Promarker diagnostic tests in America.

Clarity Pharmaceuticals’ novel diagnostic agent Cu-SAR-bisPSMA has been selected for oral presentation at the prestigious European Association of Urology Congress 2026, following promising Phase II trial results demonstrating superior detection of prostate cancer recurrence.

RocketBoots Limited has successfully raised A$7 million through a placement to accelerate its international expansion following a transformative global contract. The capital injection aims to scale its AI-driven loss-prevention platform and convert a robust enterprise pipeline.